Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 220,491 shares, an increase of 73,397.0% from the March 15th total of 300 shares. Based on an average daily trading volume, of 1,093,413 shares, the short-interest ratio is currently 0.2 days. Approximately 0.6% of the shares of the company are sold short.

Bioxytran Stock Performance

Shares of OTCMKTS BIXT opened at $0.04 on Friday. The firm has a market capitalization of $4.17 million, a P/E ratio of -1.23 and a beta of 2.50. Bioxytran has a one year low of $0.03 and a one year high of $0.20. The company’s fifty day moving average is $0.04 and its two-hundred day moving average is $0.06.

About Bioxytran

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.